Akademik Veri Yönetim Sistemi
2025 World Conference on Lung Cancer, Barcelona, İspanya, 6 - 09 Eylül 2025, ss.371-372, (Özet Bildiri)
The developments in the treatment of non-small cell lung cancer have rapidly emerged in the last decade by adding different targeted agents to the chemotherapy regimens we have been applying for the last 50 years. It seems important for our oncology practice to quickly transfer these treatment options, which have positive effects on quality of life and survival in the treatment of non-small cell lung cancer, to our daily practice and to ensure that our patients benefit from these treatment options. In this study, we investigated the reflections of newly developed treatments in our daily practice.